tiprankstipranks
Advertisement
Advertisement
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
PremiumThe FlyPsychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
20d ago
SciSparc’s Neurothera Labs announces publication of international patent
Premium
The Fly
SciSparc’s Neurothera Labs announces publication of international patent
20d ago
SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum
Premium
The Fly
SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum
22d ago
SciSparc announces 1-for-9 reverse share split
PremiumThe FlySciSparc announces 1-for-9 reverse share split
30d ago
SciSparc files to sell 23.04M ordinary shares for holders
Premium
The Fly
SciSparc files to sell 23.04M ordinary shares for holders
1M ago
SciSparc Amends $10 Million Note Deal, Issues $2 Million Initial Convertible Note
Premium
Company Announcements
SciSparc Amends $10 Million Note Deal, Issues $2 Million Initial Convertible Note
1M ago
SciSparc says Neurothera Labs granted U.S. patent for cannabinoid tech
PremiumThe FlySciSparc says Neurothera Labs granted U.S. patent for cannabinoid tech
2M ago
SciSparc Closes Acquisition of Xylo GERD Device IP, Moves to Immediate Commercialization
Premium
Company Announcements
SciSparc Closes Acquisition of Xylo GERD Device IP, Moves to Immediate Commercialization
2M ago
SciSparc completes acquisition of IP portfolio of patents, trademarks
Premium
The Fly
SciSparc completes acquisition of IP portfolio of patents, trademarks
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100